Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
At close: Oct 19, 2026
Sigyn Therapeutics Statistics
Total Valuation
SIGY has a market cap or net worth of 159,541. The enterprise value is 2.89 million.
| Market Cap | 159,541 |
| Enterprise Value | 2.89M |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SIGY has 5.32 million shares outstanding.
| Current Share Class | 5.32M |
| Shares Outstanding | 5.32M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.67% |
| Owned by Institutions (%) | 2.59% |
| Float | 4.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -417.43% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 48.78% |
| Weighted Average Cost of Capital (WACC) | 14.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.50% in the last 52 weeks. The beta is -0.05, so SIGY's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -98.50% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 47.66 |
| Average Volume (20 Days) | 27,682 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.88M |
| Pretax Income | -3.22M |
| Net Income | -3.22M |
| EBITDA | -1.88M |
| EBIT | -1.88M |
| Earnings Per Share (EPS) | -2.01 |
Balance Sheet
The company has 85,571 in cash and 2.81 million in debt, with a net cash position of -2.73 million or -0.51 per share.
| Cash & Cash Equivalents | 85,571 |
| Total Debt | 2.81M |
| Net Cash | -2.73M |
| Net Cash Per Share | -0.51 |
| Equity (Book Value) | -5.92M |
| Book Value Per Share | -3.69 |
| Working Capital | -3.90M |
Cash Flow
| Operating Cash Flow | -936,426 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2,726 |
| Net Borrowing | 857,209 |
| Free Cash Flow | -936,426 |
| FCF Per Share | -0.18 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SIGY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -28.51% |
| Shareholder Yield | -28.51% |
| Earnings Yield | -2,018.96% |
| FCF Yield | -586.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 31, 2024. It was a reverse split with a ratio of 0.025.
| Last Split Date | Jan 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |